Shanta Mancham - Publications

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients.

Journal: Oncoimmunology

Published: October 10, 2022

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma.

Journal: Cancers

Published: February 27, 2021

Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 28, 2021

HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis.

Journal: British journal of cancer

Published: April 19, 2019

Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.

Journal: Journal of hepatology

Published: October 10, 2018

GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.

Journal: International journal of cancer

Published: September 12, 2018

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.

Journal: Scientific reports

Published: July 12, 2018

Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.

Journal: Journal of surgical oncology

Published: February 16, 2018

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.

Journal: Oncoimmunology

Published: December 15, 2017

Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.

Journal: Gastroenterology

Published: December 02, 2016

Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.

Journal: International journal of cancer

Published: August 12, 2016

PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.

Journal: Oncoimmunology

Published: July 12, 2016